Solutions for Manufacturing Advanced Regenerative Therapies (SMART) CRC has been announced today by The Hon Ed Husic MP Minister for Industry and Science. AusHealth is one of the architects of the new cooperative research centre, designed to grow Australia’s biomanufacturing industry and take radical regenerative therapies out of the laboratory and into the real world. […]

Antimicrobial resistance is predicted to cause 10 million deaths by 2050. Could phage therapy be the solution? This week saw the official launch of the AusHealth Phage Therapy Centre. It’s home to a team of researchers who are taking up arms against one of the greatest challenges modern medicine faces – the rise of antimicrobial

The Platypep venom project, funded by AusHealth since 2016, has taken another step toward creating an Australian-made version of Ozempic. The research team has successfully identified a ‘hero peptide’ – derived from platypus venom – that reduces food intake, prevents weight gain and improves metabolic health in mice. The eight-week trial saw specially fattened mice

We celebrated seven exceptional PhD students working on cutting-edge research in cell and biological therapies at a formal presentation last week. They each won $10,000. Thanks to Professor Glenn King who gave a fascinating snapshot of his research – turning novel peptides found in spider venoms into life-saving drugs for heart disease, stroke, epilepsy and more.

AusHealth’s Dr Justin Coombs attended the South Australian Radioligand Therapy Roundtable, co-hosted by Novartis, the University of Adelaide and the University of South Australia. Here he explains why radioligand therapy is having a renaissance in the treatment of cancer … What is radioligand therapy? It’s a novel approach to finding and treating cancer by delivering

Revealed: some of Australia’s most exciting biotech breakthroughs In a podcast out today, AusHealth’s COO Justin Coombs sits down with Daniel Franco from Synergy IQ to talk pioneering research and how it’s being translated into Australia’s newest biotech companies. Justin discusses the business of freeing Australia’s ‘bottleneck of biotechs’ and shares some of Australia’s newest